IVI RMA GLOBAL
Cristina Barba Martos serves as a Financial Controller at IVI RMA GLOBAL, where responsibilities include analyzing financial statements across the group, participating in annual budgeting processes, and monitoring budget performance to identify deviations and implement corrective actions. Prior to this role, Cristina was the Responsable Área Clientes y Riesgos at Grupo Alimentario Citrus, overseeing risk analysis, financial reporting, accounting closures, audit preparation, and account reconciliations. Cristina began their career as a Corporate Financial Analyst at Pfizer, focusing on financial statement analysis under US GAAP and local accounting principles. Educational qualifications include a recent professional course for Controllers from CEF Centro de Estudios Financieros, a Master's in Financial Management from EAE Business School, a Bachelor's degree in Business Administration from Universidad de Castilla-La Mancha, and M&A studies at ESIC Business & Marketing School.
This person is not in any offices
IVI RMA GLOBAL
3 followers
IVIRMA Global is the world’s premier fertility group that leads the industry in research, success rates and patient care. From clinical excellence, to research and innovation, to teaching the next generation of reproductive endocrinologists, to advancing cutting edge protocols, standards and practices in the field. The acronyms IVI and RMA represent the two best assisted reproduction groups in Europe and the U.S., respectively. Together, they have since the beginning of the nineties been setting the standard in the field of reproduction, until in February 2017 they decided to merge to form the largest Reproductive Medicine group in the world. IVI was founded in 1990 by Professors José Remohí and Antonio Pellicer, and became a leader in fertility treatment in Europe and Latin America. RMA was founded in 1999 by Drs. Paul Bergh, Richard Scott and Michael Drews, quickly becoming a leader in reproductive medicine in the United States. IVI and RMA both place great importance on research, high-quality scientific results, and a common culture with a single objective: to achieve the best results for patients. • 75 Clinical Offices & 28 Labs in 9 Countries • +465 Physicians & Embryologists • +2300 Employees • +100 babies born daily thanks to IVIRMA Research & Development… • +2500 Publications • 69 Researchers • 7 Researcher centers